Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Allan Hess

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Graft vs Host Disease

Procedures

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Savage William J; Barber James P; Mukhina Galina L; Hu Rong; Chen Guibin; Matsui William; Thoburn Chris; Hess Allan D; Cheng Linzhao; Jones Richard J; Brodsky Robert A
Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.
Capriotti Elisabetta; Vonderheid Eric C; Thoburn Christopher J; Wasik Mariusz A; Bahler David W; Hess Allan D
Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.
Capriotti Elisabetta; Vonderheid Eric C; Thoburn Christopher J; Bright Emilie C; Hess Allan D
Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Allan Hess (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Savage William J; Barber James P; Mukhina Galina L; Hu Rong; Chen Guibin; Matsui William; Thoburn Chris; Hess Allan D; Cheng Linzhao; Jones Richard J; Brodsky Robert A
Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.
Experimental hematology 2009;37(1):42-51.
2008: Capriotti Elisabetta; Vonderheid Eric C; Thoburn Christopher J; Wasik Mariusz A; Bahler David W; Hess Allan D
Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.
Leukemia & lymphoma 2008;49(6):1190-201.
2007: Capriotti Elisabetta; Vonderheid Eric C; Thoburn Christopher J; Bright Emilie C; Hess Allan D
Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations.
The Journal of investigative dermatology 2007;127(12):2882-92.
2007: Bolaños-Meade Javier; Garrett-Mayer Elizabeth; Luznik Leo; Anders Viki; Webb Jennifer; Fuchs Ephraim J; Huff Carol Ann; Matsui William; Borrello Ivan M; Brodsky Robert; Kasamon Yvette L; Swinnen Lode J; Flinn Ian W; Ambinder Richard F; Jones Richard J; Hess Allan D; Vogelsang Georgia B
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1185-91.
2007: Mohamood Abdiaziz S; Guler Mehmet L; Xiao Zuoxiang; Zheng Dongfeng; Hess Allan; Wang Yi; Yagita Hideo; Schneck Jonathan P; Hamad Abdel Rahim A
Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.
The American journal of pathology 2007;171(1):97-106.
2007: Berdeja Jesús G; Hess Allan; Lucas David M; O'Donnell Paul; Ambinder Richard F; Diehl Louis F; Carter-Brookins Denise; Newton Susan; Flinn Ian W
Systemic interleukin-2 and adoptive transfer of lymphokine-activated killer cells improves antibody-dependent cellular cytotoxicity in patients with relapsed B-cell lymphoma treated with rituximab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(8):2392-9.
2006: Muthukumarana Poorni A D S; Lyons Gary E; Miura Yuji; Thompson Lorraine H; Watson Tracy; Green Colin J; Shurey Sandra; Hess Allan D; Rosengard Bruce R; Metcalfe Su M
Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerance.
International immunopharmacology 2006;6(13-14):1993-2001.
2006: Hess Allan D; Thoburn Christopher J
Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):518-29.
2006: Hess Allan D
Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1 Suppl 2):13-21.
2005: Wu Julie M; Bensen-Kennedy Debra; Miura Yuji; Thoburn Christopher J; Armstrong Deborah; Vogelsang Georgia B; Hess Allan D
The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(6):455-64.
2005: Hess Allan D; Thoburn Christopher J; Miura Yuji; Bright Emilie C
Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen.
Clinical immunology (Orlando, Fla.) 2005;114(3):307-19.
2005: Miura Y; Thoburn C J; Bright E C; Arai S; Hess A D
Regulation of OX40 gene expression in graft-versus-host disease.
Transplantation proceedings 2005;37(1):57-61.
2005: Hess A D; Thoburn C J; Miura Y; Bright E C
Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host disease.
Transplantation proceedings 2005;37(1):53-6.
2004: Miura Yuji; Thoburn Christopher J; Bright Emilie C; Phelps Michele L; Shin Tahiro; Matsui Elizabeth C; Matsui William H; Arai Sally; Fuchs Ephraim J; Vogelsang Georgia B; Jones Richard J; Hess Allan D
Association of Foxp3 regulatory gene expression with graft-versus-host disease.
Blood 2004;104(7):2187-93.
2004: Thoburn Christopher J; Miura Yuji; Bright Emilie C; Hess Allan D
Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(9):591-603.
2004: Miura Yuji; Thoburn Christopher J; Bright Emilie C; Hess Allan D
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):156-70.
2003: Miura Y; Ueda M; Takami A; Shiobara S; Nakao S; Hess A D
Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
Bone marrow transplantation 2003;32(8):785-90.
2003: Hess Allan D; Thoburn Christopher J; Chen Weiran; Bright And Emilie C
Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
Transplantation 2003;75(8):1361-7.
2002: Miura Yuji; Thoburn Christopher J; Bright Emilie C; Chen Weiran; Nakao Shinji; Hess Allan D
Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD.
Blood 2002;100(7):2650-8.
2001: Hess A D; Thoburn C; Chen W; Miura Y; Van der Wall E
The N-terminal flanking region of the invariant chain peptide augments the immunogenicity of a cryptic "self" epitope from a tumor-associated antigen.
Clinical immunology (Orlando, Fla.) 2001;101(1):67-76.
2001: Miura Y; Thoburn C J; Bright E C; Sommer M; Lefell S; Ueda M; Nakao S; Hess A D
Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.
Blood 2001;98(3):868-76.
2001: Chen W; Thoburn C J; Miura Y; Sommer M; Hruban R; Qian Z; Baldwin W; Hess A D
Autoimmune-mediated vasculopathy.
Clinical immunology (Orlando, Fla.) 2001;100(1):57-70.
2001: Hess A; Thoburn C; Chen W; Horwitz L
Autoreactive T-Cell subsets in acute and chronic syngeneic graft-versus-host disease.
Transplantation proceedings 2001;33(1-2):1754-6.
2000: van der Wall E; Horn T; Bright E; Passos-Coehlo J L; Bond S; Clarke B; Altomonte V; McIntyre K; Vogelsang G; Noga S J; Davis J M; Thomassen J; Ohly K V; Lee S M; Fetting J; Armstrong D K; Davidson N E; Hess A D; Kennedy M J
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
British journal of cancer 2000;83(11):1405-11.
2000: Hess A D
Autologous graft-versus-host disease.
Journal of hematotherapy & stem cell research 2000;9(3):297.
2000: Hess A D; Thoburn C J; Chen W; Horwitz L R
Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(1):13-24.
1999: Qian Z; Wasowska B A; Behrens E; Cangello D L; Brody J R; Kadkol S S; Horwitz L; Liu J; Lowenstein C; Hess A D; Sanfilippo F; Baldwin W M
C6 produced by macrophages contributes to cardiac allograft rejection.
The American journal of pathology 1999;155(4):1293-302.
1999: Vogelsang G; Bitton R; Piantadosi S; Altomonte V; Horn T; Jones R; Miller C; Marcellus D; Abrams R; Hess A
Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.
Bone marrow transplantation 1999;24(6):637-40.
1999: Hess A; Horwitz L; Thoburn C
Immune tolerance to self-MHC class II antigens after bone marrow transplantation.
Transplantation proceedings 1999;31(1-2):688-9.
1999: Thoburn C; Chen W; Horwitz L; Hess A
Pathogenic specificity of effector T lymphocytes in syngeneic graft-versus-host disease.
Transplantation proceedings 1999;31(1-2):684-6.
1998: Chen W; Thoburn C; Hess A D
Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(12):7040-6.
1998: O'Donnell P V; Jones R J; Vogelsang G B; Seber A; Ambinder R F; Flinn I; Miller C; Marcellus D C; Griffin C; Abrams R; Braine H G; Grever M; Hess A D; Piantadosi S; Noga S J
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
Bone marrow transplantation 1998;22(10):947-55.
1998: Noga S J; Seber A; Davis J M; Berenson R J; Vogelsang G B; Braine H G; Hess A D; Marcellus D; Miller C A; Sharkis S J; Goodman S N; Santos G W; Jones R J
CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment.
Journal of hematotherapy 1998;7(2):151-7.
1998: Hess A D; Thoburn C; Horwitz L
Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease: specificity of cytolytic effector T cells.
Transplantation 1998;65(6):785-92.
1997: Hess A D; Thoburn C J
Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease.
Immunological reviews 1997;157():111-23.
1997: Hess A D; Bright E C; Thoburn C; Vogelsang G B; Jones R J; Kennedy M J
Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide.
Blood 1997;89(6):2203-9.
1997: Noga S J; Vogelsang G B; Seber A; Davis J M; Schepers K; Hess A D; Jones R J
CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity.
Transplantation proceedings 1997;29(1-2):728-32.
1997: Hess A; Thoburn C; Bright E; Horwitz L
Specificity of effector mechanisms in syngeneic graft-vs-host disease: recognition of the MHC class II invariant chain peptide (CLIP).
Transplantation proceedings 1997;29(1-2):725-7.
1997: Hess A; Ruvolo P; Fischer A; Horwitz L; Bright E; Thoburn C
Characterization of the V alpha/V beta autoreactive T-cell repertoire in syngeneic graft-vs-host disease.
Transplantation proceedings 1997;29(1-2):709-11.
1996: Ibrahim S; Jakobs F; Kittur D; Hess A; Linsley P S; Sanfilippo F; Baldwin W M
CTLA4Ig inhibits alloantibody responses to repeated blood transfusions.
Blood 1996;88(12):4594-600.
1996: Beschorner W E; Qian Z; Mattei P; Hess A D; Colombani P M; Sciscione A C; Khouzami A; Blakemore K J; Burdick J F
Induction of human chimerism and functional suppressor cells in fetal pigs: feasibility of surrogate tolerogenesis for xenotransplantation.
Transplantation proceedings 1996;28(2):648-9.
1995: Hess A D; Kennedy M J; Ruvolo P P; Vogelsang G B; Jones R J
Antitumor activity of syngeneic/autologous graft-versus-host disease.
Annals of the New York Academy of Sciences 1995;770():189-202.
1995: Kennedy M J; Hess A D
Autologous graft-versus-host disease.
Medical oncology (Northwood, London, England) 1995;12(3):149-56.
1995: Esa A H; Warren J T; Hess A D; May W S
Bryostatins trigger human polymorphonuclear neutrophil and monocyte oxidative metabolism: association with in vitro antineoplastic activity.
Research in immunology 1995;146(6):351-61.
1995: Ruvolo P P; Fischer A C; Vogelsang G B; Jones R J; Hess A D
Analysis of the V beta T-cell receptor repertoire in autologous graft-versus-host disease.
Annals of the New York Academy of Sciences 1995;756():432-4.
1995: Zhang H; Horwitz L; Ruvolo P; Colombani P; Hess A D
The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection.
Transplantation 1995;60(2):115-22.
1995: Burt R K; Burns W; Hess A
Bone marrow transplantation for multiple sclerosis.
Bone marrow transplantation 1995;16(1):1-6.
1995: Burt R K; Burns W; Ruvolo P; Fischer A; Shiao C; Guimaraes A; Barrett J; Hess A
Syngeneic bone marrow transplantation eliminates V beta 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis.
Journal of neuroscience research 1995;41(4):526-31.
1995: Brauer R B; Lam T T; Wang D; Horwitz L R; Hess A D; Klein A S; Sanfilippo F; Baldwin W M
Extrahepatic synthesis of C6 in the rat is sufficient for complement-mediated hyperacute rejection of a guinea pig cardiac xenograft.
Transplantation 1995;59(7):1073-6.
1995: Fischer A C; Ruvolo P P; Burt R; Horwitz L R; Bright E C; Hess J M; Beschorner W E; Hess A D
Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(8):3713-25.
1995: Thoburn C J; Hess A D
Bryostatin can induce antigen-specific nonresponsiveness in human peripheral blood T cells.
Transplantation proceedings 1995;27(1):443-4.
1995: Hess A D; Fischer A C; Horwitz L R; Bright E C; Hess J M
Immunological mechanisms governing tolerance to self-major histocompatibility complex antigens after bone marrow transplantation.
Transplantation proceedings 1995;27(1):1370-3.
1995: Fischer A C; Ruvolo P P; Horwitz L R; Hess A D
Analysis of V beta T-cell receptor repertoire of effector mechanisms in acute and chronic graft versus host disease.
Transplantation proceedings 1995;27(1):1366-9.
1995: Ruvolo P; Bright E; Kennedy M J; Morris L; Fischer A; Vogelsang G; Jones R; Hess A
Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.
Transplantation proceedings 1995;27(1):1363-5.
1995: Fuchs E J; Bedi A; Jones R J; Hess A D
Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis.
Cancer research 1995;55(3):463-6.
1994: Brauer R B; Baldwin W M; Wang D; Horwitz L R; Hess A D; Klein A S; Sanfilippo F
Hepatic and extrahepatic biosynthesis of complement factor C6 in the rat.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(7):3168-76.
1994: Vogelsang G B; Hess A D
Graft-versus-host disease: new directions for a persistent problem.
Blood 1994;84(7):2061-7.
1994: Horn T D; Bauer D J; Vogelsang G B; Hess A D
Reappraisal of histologic features of the acute cutaneous graft-versus-host reaction based on an allogeneic rodent model.
The Journal of investigative dermatology 1994;103(2):206-10.
1994: Hess A D; Fischer A C; Horwitz L; Bright E C; Laulis M K
Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(1):400-11.
1994: Kennedy M J; Vogelsang G B; Jones R J; Farmer E R; Hess A D; Altomonte V; Huelskamp A M; Davidson N E
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):249-57.
1993: Hess A D; Horwitz L R; Laulis M K; Fuchs E
Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.
Clinical immunology and immunopathology 1993;69(3):341-50.
1993: Yeager A M; Vogelsang G B; Jones R J; Farmer E R; Hess A D; Santos G W
Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia.
Leukemia & lymphoma 1993;11(3-4):215-20.
1993: Hess A D; Fischer A C; Horwitz L R; Laulis M K
Cyclosporine-induced autoimmunity: critical role of autoregulation in the prevention of major histocompatibility class II-dependent autoaggression.
Transplantation proceedings 1993;25(5):2811-3.
1993: Noga S J; Hess A D
Lymphocyte depletion in bone marrow transplantation: will modulation of graft-versus-host disease prove to be superior to prevention?
Seminars in oncology 1993;20(5 Suppl 6):28-33.
1993: Pozsgay J M; Beilharz M W; Wines B D; Hess A D; Pitha P M
The MA (p15) and p12 regions of the gag gene are sufficient for the pathogenicity of the murine AIDS virus.
Journal of virology 1993;67(10):5989-99.
1993: Liu S H; Zhou D H; Hess A D
Adoptive transfer of experimental autoimmune dacryoadenitis in susceptible and resistant mice.
Cellular immunology 1993;150(2):311-20.
1993: Hess A D
Mechanisms of action of cyclosporine: considerations for the treatment of autoimmune diseases.
Clinical immunology and immunopathology 1993;68(2):220-8.
1993: Liu S H; Zhou D H; Gottsch J D; Hess A D
Treatment of experimental autoimmune dacryoadenitis with cyclosporin A.
Clinical immunology and immunopathology 1993;67(1):78-83.
1993: Hess A D; Horwitz L R; Laulis M K
Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
Transplantation proceedings 1993;25(1 Pt 2):1218-21.
1993: Vogelsang G B; Hess A D
Rapamycin effects on immunologic reconstitution.
Transplantation proceedings 1993;25(1 Pt 1):727-8.
1993: Severino M E; Laulis M K; Horwitz L R; Hess A D
Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor.
Transplantation proceedings 1993;25(1 Pt 1):520-3.
1993: Hess A D; Jones R C; Santos G W
Autologous graft-vs-host disease: mechanisms and potential therapeutic effect.
Bone marrow transplantation 1993;12 Suppl 3():S65-9.
1992: Hess A D; Jones R J; Morris L E; Noga S J; Vogelsang G B; Santos G W
Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy.
Human immunology 1992;34(3):219-24.
1992: Yeager A M; Vogelsang G B; Jones R J; Farmer E R; Altomonte V; Hess A D; Santos G W
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
Blood 1992;79(11):3031-5.
1992: Vogelsang G B; Farmer E R; Hess A D; Altamonte V; Beschorner W E; Jabs D A; Corio R L; Levin L S; Colvin O M; Wingard J R
Thalidomide for the treatment of chronic graft-versus-host disease.
The New England journal of medicine 1992;326(16):1055-8.
1992: Hess A D; Jones R J; Morris L E; Noga S J; Yeager A M; Vogelsang G B; Santos G W
Autologous graft-versus-host disease: a new frontier in immunotherapy.
Bone marrow transplantation 1992;10 Suppl 1():16-21.
1992: Noga S J; Horwitz L; Kim H; Laulis M K; Hess A D
Interferon-gamma potentiates the antitumor effect of cyclosporine-induced autoimmunity.
Journal of hematotherapy 1992;1(1):75-84.
1991: Levine B L; May W S; Tyler P G; Hess A D
Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(10):3474-81.
1991: Beschorner W E; Ren H; Phillips J; Pulido H B; Hruban R H; Hess A D
Prevention of syngeneic graft-versus-host disease by recovery of thymic microenvironment after cyclosporine.
Transplantation 1991;52(4):668-74.
1991: Hess A D; Bright E C
The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Transplantation 1991;51(6):1232-40.
1991: Hess A D; Bright E C
Cyclosporine inhibits T-cell activation at two distinct levels: role of the CD 28 activation pathway.
Transplantation proceedings 1991;23(1 Pt 2):961-6.
1991: Schuchter L M; Esa A H; May S; Laulis M K; Pettit G R; Hess A D
Successful treatment of murine melanoma with bryostatin 1.
Cancer research 1991;51(2):682-7.
1991: Fischer A C; Laulis M K; Horwitz L; Hess A D
Effect of cyclosporine on T lymphocyte development. Relationship to syngeneic graft-versus-host disease.
Transplantation 1991;51(1):252-9.
1990: Fischer A C; Hess A D
Age-related factors in cyclosporine-induced syngeneic graft-versus-host disease: regulatory role of marrow-derived T lymphocytes.
The Journal of experimental medicine 1990;172(1):85-94.
1990: Shinozawa T; Beschorner W E; Hess A D
The thymus and prolonged administration of cyclosporine. Irreversible immunopathologic changes associated with autologous pseudo-graft-versus-host disease.
Transplantation 1990;50(1):106-11.
1990: Hess A D; Fischer A C; Beschorner W E
Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(2):526-33.
1990: Esa A H; Boto W O; Adler W H; May W S; Hess A D
Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
International journal of immunopharmacology 1990;12(5):481-90.
1990: Noga S J; Fischer A C; Horwitz L R; Donnenberg A D; Wagner J E; Hess A D
Elutriation of bone marrow delineates two distinct natural suppressor cell populations.
Progress in clinical and biological research 1990;333():363-8.
1990: Noga S J; Wagner J E; Rowley S D; Davis J M; Vogelsang G B; Hess A D; Saral R; Santos G W; Donnenberg A D
Using elutriation to engineer bone marrow allografts.
Progress in clinical and biological research 1990;333():345-59; discussion 360-1.
1989: Hess A D; Fischer A C
Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.
Transplantation 1989;48(6):895-900.
1989: Fischer A C; Laulis M K; Horwitz L; Beschorner W E; Hess A
Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(3):827-32.
1989: Geller R B; Esa A H; Beschorner W E; Frondoza C G; Santos G W; Hess A D
Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat.
Blood 1989;74(3):1165-71.
1989: Vogelsang G B; Hess A D; Friedman K J; Santos G W
Therapy of chronic graft-v-host disease in a rat model.
Blood 1989;74(1):507-11.
1989: Jones R J; Vogelsang G B; Hess A D; Farmer E R; Mann R B; Geller R B; Piantadosi S; Santos G W
Induction of graft-versus-host disease after autologous bone marrow transplantation.
Lancet 1989;1(8641):754-7.
1989: Fischer A C; Beschorner W E; Hess A D
Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease.
The Journal of experimental medicine 1989;169(3):1031-41.
1989: Wells M S; Vogelsang G B; Colombani P M; Hess A D
Cyclosporin A binding to calmodulin.
Transplantation proceedings 1989;21(1 Pt 1):850-2.
1989: Colombani P M; Bright E C; Wells M; Hess A D
Drug-drug interaction between cyclosporine and agents affecting calcium-dependent lymphocyte proliferation.
Transplantation proceedings 1989;21(1 Pt 1):840-1.
1989: Fischer A C; Beschorner W E; Hess A D
Age-related factors in the induction of syngeneic GVHD.
Transplantation proceedings 1989;21(1 Pt 3):3033-5.
1989: Vogelsang G B; Jones R J; Hess A D; Geller R; Schucter L; Santos G W
Induction of autologous graft-versus-host disease.
Transplantation proceedings 1989;21(1 Pt 3):2997-8.
1989: Hess A D; Fischer A C; Beschorner W E
Regulation of syngeneic graft-versus-host disease by autosuppressor mechanisms.
Transplantation proceedings 1989;21(1 Pt 3):3013-5.
1989: Beschorner W E; Shinn C A; Hess A D; Suresch D L; Santos G W
Immune-related injury to endothelium associated with acute graft-versus-host disease in the rat.
Transplantation proceedings 1989;21(1 Pt 3):3025-7.
1989: Scheibel L W; Colombani P M; Hess A D; Aikawa M; Atkinson C T; Igarashi I; Matsumoto Y; Milhous W K
Calcium/calmodulin functions in P. falciparum in vitro--implications for antiprotozoal drug design.
Progress in clinical parasitology 1989;1():21-56.
1988: Newsome D A; Quinn T C; Hess A D; Pitha-Rowe P M
Cellular immune status in retinitis pigmentosa.
Ophthalmology 1988;95(12):1696-703.
1988: Hess A D; Silanskis M K; Esa A H; Pettit G R; May W S
Activation of human T lymphocytes by bryostatin.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(10):3263-9.
1988: Vogelsang G B; Hess A D; Santos G W
Thalidomide for treatment of graft-versus-host disease.
Bone marrow transplantation 1988;3(5):393-8.
1988: Beschorner W E; Shinn C A; Fischer A C; Santos G W; Hess A D
Cyclosporine-induced pseudo-graft-versus-host disease in the early post-cyclosporine period.
Transplantation 1988;46(2 Suppl):112S-117S.
1988: Hess A D; Colombani P M
Inverse correlation of cyclosporine binding with sensitivity and resistance.
Transplantation 1988;46(2 Suppl):61S-67S.
1988: Beschorner W E; Suresch D L; Shinozawa T; Santos G W; Hess A D
Thymic immunopathology after cyclosporine: effect of irradiation and age on medullary involution and recovery.
Transplantation proceedings 1988;20(3 Suppl 3):1072-8.
1988: Fischer A C; Beschorner W E; Hess A D
Syngeneic graft-versus-host disease: failure of autoregulation in self/non-self discrimination.
Transplantation proceedings 1988;20(3 Suppl 3):493-500.
1988: Hess A D; Vogelsang G B; Silanskis M; Friedman K A; Beschorner W E; Santos G W
Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
Transplantation proceedings 1988;20(3 Suppl 3):487-92.
1988: Noga S J; Fischer A C; Wagner J E; Normann S J; Zucali J R; Esa A E; Hess A D
Cyclosporine A enhances the natural suppressor monocyte precursor population in the rat.
Transplantation proceedings 1988;20(3 Suppl 3):1057-67.
1988: Vogelsang G B; Hess A D; Santos G W
Acute graft-versus-host disease: clinical characteristics in the cyclosporine era.
Medicine 1988;67(3):163-74.
1988: Vogelsang G B; Wells M C; Santos G W; Chen T L; Hess A D
Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model.
Transplantation proceedings 1988;20(2 Suppl 2):226-8.
1988: Beschorner W E; Olson J L; Hess A D; Di Gennaro K A; Santos G W
Cyclosporine-induced cell-mediated injury of the thymic medullary epithelium.
Transplantation 1988;45(4):797-803.
1988: Esa A H; Paxman D G; Noga S J; Hess A D
Sensitivity of monocyte subpopulations to cyclosporine. Arachidonate metabolism and in vitro antigen presentation.
Transplantation proceedings 1988;20(2 Suppl 2):80-6.
1988: Colombani P M; Bright E C; Hess A D
Comparison of binding to peripheral blood lymphocytes between active and inactive derivatives of cyclosporine.
Transplantation proceedings 1988;20(2 Suppl 2):46-50.
1988: Hess A D; Esa A H; Colombani P M
Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation.
Transplantation proceedings 1988;20(2 Suppl 2):29-40.
1988: Wagner J E; Donnenberg A D; Noga S J; Wiley J M; Yeager A M; Vogelsang G B; Hess A D; Santos G W
Separation of rat bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletion.
Experimental hematology 1988;16(3):206-12.
1988: Noga S J; Wagner J E; Horwitz L R; Donnenberg A D; Santos G W; Hess A D
Characterization of the natural suppressor cell population in adult rat bone marrow.
Journal of leukocyte biology 1988;43(3):279-87.
1988: Beschorner W E; Hess A D; Shinn C A; Santos G W
Transfer of cyclosporine-associated syngeneic graft-versus-host disease by thymocytes. Resemblance to chronic graft-versus-host disease.
Transplantation 1988;45(1):209-15.
1987: Beschorner W E; Di Gennaro K A; Hess A D; Santos G W
Cyclosporine and the thymus: influence of irradiation and age on thymic immunopathology and recovery.
Cellular immunology 1987;110(2):350-64.
1987: Donnenberg A D; Hess A D; Duff S C; Bright E C; Noga S J; Rowley S D; Saral R; Santos G W
Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxis.
Transplantation proceedings 1987;19(6 Suppl 7):144-52.
1987: Colombani P M; Hess A D
T-lymphocyte inhibition by cyclosporine. Potential mechanisms of action.
Biochemical pharmacology 1987;36(22):3789-93.
1987: Scheibel L W; Colombani P M; Hess A D; Aikawa M; Atkinson C T; Milhous W K
Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(20):7310-4.
1987: Hess A D; Colombani P N
Cyclosporin-resistant and -sensitive T-lymphocyte subsets.
Annales de l'Institut Pasteur. Immunology 1987;138(4):606-11.
1987: Beschorner W E; Namnoum J D; Hess A D; Shinn C A; Santos G W
Cyclosporin A and the thymus. Immunopathology.
The American journal of pathology 1987;126(3):487-96.
1987: Hess A D; Vogelsang G B; Heyd J; Beschorner W E
Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation.
Transplantation proceedings 1987;19(1 Pt 3):2683-6.
1987: Vogelsang G B; Hess A D; Gordon G; Brundrette R; Santos G W
Thalidomide induction of bone marrow transplantation tolerance.
Transplantation proceedings 1987;19(1 Pt 3):2658-61.
1987: Beschorner W E; Namnoum J D; Hess A D
Immunopathology of rat thymus after cyclosporine A.
Transplantation proceedings 1987;19(1 Pt 2):1230-5.
1987: Esa A H; Vogelsang G B; Sandford G R; Saral R; Hess A D; Burns W H
Cell-mediated immune responses in rat cytomegalovirus infection.
Transplantation proceedings 1987;19(1 Pt 3):2726-9.
1987: Colombani P M; Bright E C; Monastyrskyj O; Hess A D
Subcellular action of cyclosporine: interaction between CsA and calmodulin antagonists.
Transplantation proceedings 1987;19(1 Pt 2):1171-4.
1987: Aszalos A; Damjanovich S; Colombani P; Hess A
Lymphocyte populations with different sensitivity to cyclosporin have different plasma membrane potentials.
Journal of medicine 1987;18(5-6):351-74.
1987: Esa A H; Converse P J; Hess A D
Cyclosporine inhibits soluble antigen and alloantigen presentation by human monocytes in vitro.
International journal of immunopharmacology 1987;9(8):893-902.
1987: Hess A D; Colombani P M
Mechanism of action of cyclosporine: a unifying hypothesis.
Advances in experimental medicine and biology 1987;213():309-30.
1987: Colombani P M; Hess A D
Fluorometric and flow cytometric analysis of the cyclosporine-calmodulin interaction in T lymphocytes.
Methods in enzymology 1987;139():677-90.
1986: Hess A D; Colombani P M
Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
Transplantation proceedings 1986;18(6 Suppl 5):219-37.
1986: Esa A H; Noga S J; Donnenberg A D; Hess A D
Immunological heterogeneity of human monocyte subsets prepared by counterflow centrifugation elutriation.
Immunology 1986;59(1):95-9.
1986: Vogelsang G B; Hess A D; Gordon G; Santos G W
Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model.
Transplantation 1986;41(5):644-7.
1986: Simons J W; Noga S J; Colombani P M; Beschorner W E; Coffey D S; Hess A D
Cyclosporine A, an in vitro calmodulin antagonist, induces nuclear lobulations in human T cell lymphocytes and monocytes.
The Journal of cell biology 1986;102(1):145-50.
1986: Hess A D; Colombani P M; Esa A H
Cyclosporine and the immune response: basic aspects.
Critical reviews in immunology 1986;6(2):123-49.
1986: Hess A D; Colombani P M
Cyclosporin. Mechanism of action: in vitro studies.
Progress in allergy 1986;38():198-221.
1985: Santos G W; Hess A D; Vogelsang G B
Graft-versus-host reactions and disease.
Immunological reviews 1985;88():169-92.
1985: Vogelsang G B; Hess A D; Berkman A W; Tutschka P J; Farmer E R; Converse P J; Santos G W
An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants.
The New England journal of medicine 1985;313(11):645-50.
1985: Colombani P M; Robb A; Hess A D
Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes.
Science (New York, N.Y.) 1985;228(4697):337-9.
1985: Hess A D; Horwitz L; Beschorner W E; Santos G W
Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.
The Journal of experimental medicine 1985;161(4):718-30.
1985: Converse P J; Hess A D
Effect of cyclosporin and interleukin-2 on the restoration of in vitro immune responses to cytomegalovirus.
Scandinavian journal of immunology 1985;21(2):109-18.
1985: Hess A D
Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
Transplantation 1985;39(1):62-8.
1985: Hess A D; Santos G W
Induction of suppressor lymphocytes in lymphohematopoietic chimeras.
The Year in immunology 1985;():51-61.
1984: Glazier A; Morison W L; Bucana C; Hess A D; Tutschka J
Suppression of epidermal graft-versus-host disease with ultraviolet radiation.
Transplantation 1984;37(2):211-3.
1983: Converse P J; Hess A D; Tutschka P J; Santos G W
Effect of cyclosporine on the response of normal human lymphocytes to cytomegalovirus in vitro.
Infection and immunity 1983;41(3):1226-33.
1983: Wingard J R; Hess A D; Stuart R K; Saral R; Burns W H
Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation.
Antimicrobial agents and chemotherapy 1983;23(4):593-7.
1983: Tutschka P J; Beschorner W E; Hess A D; Santos G W
Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants.
Blood 1983;61(2):318-25.
1983: Hess A D; Donnenberg A D; Tutschka P J; Santos G W
Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1983;130(2):717-21.
1982: Körbling M; Hess A D; Tutschka P J; Kaizer H; Colvin M O; Santos G W
4-hydroperoxycyclophosphamide: a model for eliminating residual human tumour cells and T-lymphocytes from the bone marrow graft.
British journal of haematology 1982;52(1):89-96.
1982: Tutschka P J; Hess A D; Beschorner W E; Santos G W
Suppressor cells in transplantation tolerance. III. The role of antigen in the maintenance of transplantation tolerance.
Transplantation 1982;33(5):510-4.
1982: Hess A D; Tutschka P J; Pu Z; Santos G W
Effect of cyclosporin A on human lymphocyte responses in vitro. IV. Production of T cell stimulatory growth factors and development of responsiveness to these growth factors in CsA-treated primary MLR cultures.
Journal of immunology (Baltimore, Md. : 1950) 1982;128(1):360-7.
1982: Hess A D; Tutschka P J; Santos G W
Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.
Journal of immunology (Baltimore, Md. : 1950) 1982;128(1):355-9.
1982: Hess A D
Cyclosporin A and the immune response to transplantation antigens.
Lymphokine research 1982;1(2):23-7.
1981: Tutschka P J; Ki P F; Beschorner W E; Hess A D; Santos G W
Suppressor cells in transplantation tolerance. II. maturation of suppressor cells in the bone marrow chimera.
Transplantation 1981;32(4):321-5.
1981: Tutschka P J; Hess A D; Beschorner W E; Santos G W
Suppressor cells in transplantation tolerance. I. Suppressor cells in the mechanism of tolerance in radiation chimeras.
Transplantation 1981;32(3):203-9.
1981: Hess A D; Tutschka P J; Santos G W
In vitro activation of human suppressor cells: relative quantitation and specificity of suppressor cells generated in primary and secondary mixed lymphocyte cultures.
Experimental hematology 1981;9(4):415-30.
1981: Tutschka P J; Körbling M; Hess A D; Beschorner W E; Santos G W
Prevention of graft-versus-host disease (GVHD) by chemoseparation of marrow cells.
Transplantation proceedings 1981;13(1 Pt 2):1202-6.
1981: Hess A D; Tutschka P J; Santos G W
Effect of cyclosporin-A on human lymphocyte responses in vitro--induction of tolerance to alloantigens.
Transplantation proceedings 1981;13(1 Pt 1):374-8.
1981: Hess A D; Tutschka P J; Santos G W
Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(3):961-8.
1981: Hubbard W J; Hess A D; Hsia S; Amos D B
The effects of electrophoretically "slow" and "fast" alpha-2 macroglobulin on mixed lymphocyte cultures.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(1):292-9.
1980: Hess A D; Gall S A; Dawson J R
Inhibition of human lymphoblastoid cell line proliferation by ascites fluids from ovarian cancer patients.
Cancer research 1980;40(12):4495-500.
1980: Zander A R; Sarpell S; Cunningham B; Hess A D; Johnston D A; Epstein R B
Plasmapheresis as immunotherapeutic modality in the treatment of the canine venereal tumor.
Experimental hematology 1980;8(9):1123-8.
1980: Hess A D; Gall S A; Dawson J R
Partial purification and characterization of a lymphocyte-inhibitory factor(s) in ascitic fluids from ovarian cancer patients.
Cancer research 1980;40(6):1842-51.
1980: Hess A D; Tutschka P J
Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(6):2601-8.
1980: Tutschka P J; Beschorner W E; Hess A D
Use of cyclosporin A (CsA) in a rat model of allogeneic marrow transplantation.
Haematology and blood transfusion 1980;25():241-53.
1980: Zander A R; Hess A D; Epstein R B
Immunosuppressive effects of rabbit anti-canine brain serum.
Experimentelle Pathologie 1980;18(5):310-3.
1979: Beschorner W E; Hess A D; Nerenberg S T; Epstein R B
Isolation and characterization of canine venereal tumor-associated inhibitory and blocking factors.
Cancer research 1979;39(10):3920-7.
1979: Hess A D; Gall S A; Dawson J R
Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients.
Cancer research 1979;39(7 Pt 1):2381-9.
1977: Hess A D; Catchatourian R; Zander A R; Epstein R B
Intralesional Bacillus Calmette-Guérin immunotherapy of canine venereal tumors.
Cancer research 1977;37(11):3990-4.
1975: Hess A; Cunningham B; Taylor Bennett B; Epstein R
In vitro correlates of the in vivo course of the canine transmissible venereal tumor studied by mixed lymphocyte-tumor cultures.
Transplantation proceedings 1975;7(4):507-11.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Allan Hess

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Allan Hess (preview)

All Publications